He Ao Pohewa: The PHARMAC Prescription for Pharmacoeconomic Analysis in New Zealand and the Standards of Normal Science
In common with a number of other single payer health systems, New Zealand has, through the Pharmaceutical Management Agency (PHARMAC), established guidelines for formulary submissions by pharmaceutical manufacturers. A question that is important to health system decision makers is to whether or not...
Main Author: | Paul C Langley |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Minnesota Libraries Publishing
2016-07-01
|
Series: | INNOVATIONS in Pharmacy |
Subjects: | |
Online Access: | https://pubs.lib.umn.edu/index.php/innovations/article/view/436 |
Similar Items
-
Imaginary Worlds: Modeled claims for cost-effectiveness published in PharmacoEconomics January 2015 to December 2015
by: Paul C Langley
Published: (2016-07-01) -
Imaginary Worlds: A Systematic Review of the Status of Modeled Cost-Effectiveness Claims Published in the Journal of Medical Economics from January 2015 to December 2015
by: Paul C Langley, et al.
Published: (2016-07-01) -
Great Expectations: Cost-Utility Models as Decision Criteria
by: Paul C Langley
Published: (2016-07-01) -
Supporting Formulary Decisions: The Discovery of New Facts or Constructed Evidence?
by: Paul C Langley
Published: (2016-07-01) -
Imaginary Worlds: The Status of Modeled Economic Evaluation Claims Published in Value in Health January 2015 to December 2015
by: Paul C Langley, et al.
Published: (2016-07-01)